(Webinar) Managing Type II Diabetes Mellitus (Part 9)
Duration: 27:26
Published On Jun 2, 2017
Dr. Syed discusses properties, mechanism of action, metabolism, clinical use, dosage, side effects, and contraindications for biguanides/Sulfonylureases.
In this video we will learn about:
1. Sulfonylurea and the rationale of use.
2. Mechanism of actions and metabolism.
3. Administration protocol.
4. Drug interactions and titrations.
5. First and second generation secretagogues.
6. Side effects.
Presented by Dr. Mobeen Syed
Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.
Instructors
Pharmacology
Clinical Application of Cardiac Drugs/Cardiac Pharmacology
27:29
Ahmed Zaafran, MD
Clinical Applications of Anti-Dysrhythmia Drugs
20:05
Ahmed Zaafran, MD
Clinical Applications of Anti-Inflammatory/Anti-Histamine Drugs
36:23
Ahmed Zaafran, MD
Clinical Applications of Antihypertensive Drugs (Part 1)
19:02
Ahmed Zaafran, MD
Diagnosis and Management of Hypertension
48:55
Ahmed Zaafran, MD
Clinical Application of Cardiac Drugs/Cardiac Pharmacology
27:29
Ahmed Zaafran, MD
0.50 CME
Management of Atrial Fibrillation
34:02
Dr. Mobeen Syed
Cardiac Drugs: Inotropes, Vasopressors, and Vasodilators Part 1
33:33
Luis A Verduzco M.D.
Cardiac Drugs: Inotropes, Vasopressors, and Vasodilators Part 2
48:59
Luis A Verduzco M.D.
0.50 CME
Low Dose Naltrexone (LDN) - Mechanism of Action
34:43
Dr. Mobeen Syed
0.50 CME
Future Antivirals Using Bacterial Immune Sensors
26:02
Dr. Mobeen Syed
(Webinar) Managing Type II Diabetes Mellitus (Part 9)
27:26
Dr. Mobeen Syed
(Webinar) Managing Type II Diabetes Mellitus (Part 10)
29:05
Dr. Mobeen Syed
Metformin and General Considerations to Mange Type II Diabetes Mellitus (Managing Type II Diabetes Mellitus - Part 8. Webinar)
47:37
Dr. Mobeen Syed
Drug Classes to Manage Type II Diabetes Mellitus (Managing Type II Diabetes Mellitus - Part 7. Webinar)
40:48
Dr. Mobeen Syed
(Webinar) Dyslipidemia Management-ACC/AHA guideline Overview
44:42
Dr. Mobeen Syed
1.50 CME
Insulin Synthesis, Secretion, and Regulation
1:34:58
Dr. Mobeen Syed
1.50 CME
Master Insulin Therapy (full video)
1:22:37
Dr. Mobeen Syed
How Does Ozempic Work?
25:07
Dr. Mobeen Syed
0.75 CME
Clinical Application of Cholinergic Drugs/Cholinergic System
51:32
Ahmed Zaafran, MD
0.50 CME
Clinical Applications of Respiratory Drugs (Part 1)/ Asthma
26:05
Ahmed Zaafran, MD
0.50 CME
Clinical Application of Respiratory Drugs (Part2) / Asthma
22:41
Ahmed Zaafran, MD
0.25 CME
Clinical Applications of Anti-Histamine Medications (Part 1)/Common Cold
19:06
Ahmed Zaafran, MD
0.25 CME
Clinical Applications of Anti-Histamine Drugs (Part 2)/Common Cold
19:41
Ahmed Zaafran, MD
1.25 CME
(Webinar) Peptic Ulcer Disease and the Role of PPIs
1:13:38
Sameer Islam, MD
Overview of the Pediatric Vaccination Schedules
1:56:21
Tammy Wang, MD
0.21 CME
Penicillin: Mechanism of Action
12:15
Dr. Mobeen Syed
0.75 CME
Sedation and Analgesia
51:09
Luis A Verduzco M.D.
0.12 CME
Nitric Oxide
07:12
Dr. Mobeen Syed
0.50 CME
How Dostarlimab Therapy Healed Colorectal Cancer
31:04
Dr. Mobeen Syed
Potential New Killer Cells for Cancer Immunotherapy
30:23
Dr. Mobeen Syed
Story of Ivermectin Nobel Prize
16:50
Dr. Mobeen Syed
1.00 CME
Opioid Receptor Activation and Tolerance (Pain Part 5)
53:40
Dr. Mobeen Syed
Omega-6 to Omega-3 Ratio
31:33
Dr. Mobeen Syed
Omega-3 Dietary Sources and Quantities
21:52
Dr. Mobeen Syed
Merck’s Molnupiravir (EIDD-281) Effective Against SARS-COV-2
29:11
Dr. Mobeen Syed
Maraviroc Mechanism of Action (MOA)
32:44
Dr. Mobeen Syed
Low Histamine Diets
19:50
Dr. Mobeen Syed
IVIg A High Level Overview
23:23
Dr. Mobeen Syed
Mixing Vaccine Types - UK Study
12:18
Dr. Mobeen Syed
Administration of Second Dose Of Moderna Vaccine After An Immediate Hypersensitivity Reaction to The First Dose
10:46
Dr. Mobeen Syed
Nasal Spray for Virus/SARS-COV-2 Reduction
21:28
Dr. Mobeen Syed
How is AstraZeneca Vaccine Made
07:06
Dr. Mobeen Syed
Covaxin, A Vaccine from India
30:56
Dr. Mobeen Syed
Sputnik Vaccine is 91.6% Effective
19:30
Dr. Mobeen Syed
Interferon Beta - A New Study
18:05
Dr. Mobeen Syed
Vitamin D, Dust and Covid-19
15:42
Dr. Mobeen Syed
Regeneron Antibody Cocktail
08:53
Dr. Mobeen Syed
0.50 CME
Macrolide - Azithromycin
24:12
Dr. Mobeen Syed
Famotidine (H2 Receptor Antagonist)
28:20
Dr. Mobeen Syed
Norepinephrine
32:19
Dr. Mobeen Syed
Favipiravir
26:05
Dr. Mobeen Syed
Iodine and Its Medical Uses
26:07
Dr. Mobeen Syed
Dexamethasone
28:41
Dr. Mobeen Syed
0.50 CME
COVID-19 and Aspirin
28:13
Dr. Mobeen Syed
Magnesium
35:04
Dr. Mobeen Syed
Melatonin
30:38
Dr. Mobeen Syed
Tocilizumab An IL6 Receptor Blocker
34:49
Dr. Mobeen Syed
Camostat Mesylate
25:14
Dr. Mobeen Syed
0.50 CME
NAC N-Acetylcysteine
27:41
Dr. Mobeen Syed
Convalescent Plasma For COVID-19 Patients
50:28
Dr. Mobeen Syed
Androgens Physiological and Pharmacological Aspects (Lecture 1)
29:33
Dr. Mobeen Syed
Androgens - What Controls Androgen Release (Lecture 2)
28:44
Dr. Mobeen Syed
Antiandrogens - A High-Level Overview (Lecture 3)
35:26
Dr. Mobeen Syed
Study - Antiandrogens Reduce COVID Hospitalization, Deaths, And Disease Progress
19:22
Dr. Mobeen Syed
Study - Antiandrogens (Dutasteride) For Mild COVID Cases
20:13
Dr. Mobeen Syed
Write A New Comment
2 Comments
longstanding2001@*.com
Jan 30 2026, 1:36 am
PHENYL BUTAZONE IS NO LONGER USED
longstanding2001@*.com
Jan 30 2026, 1:36 am
PHENYL BUTAZONE IS NO LONGER USED